Charcot-Marie-Tooth Slow Nerve Conduction Type C

Charcot-Marie-Tooth slow nerve conduction type C is a rare inherited nerve disease that mainly affects the long nerves in the arms and legs. It belongs to the group called Charcot-Marie-Tooth disease type 1 (CMT1), which are “demyelinating” neuropathies. In this type, the insulating covering of the nerve (myelin) is damaged, so nerve signals travel more slowly than normal.MalaCards+1

Charcot-Marie-Tooth (CMT) slow nerve conduction type C is a hereditary peripheral neuropathy. This means the long nerves that carry signals to and from the arms and legs work slowly and weakly because of changes in the genes that build myelin or nerve fibers. In type C, nerve conduction is clearly slower than normal, so messages from the brain move more slowly to the muscles. Over years, this can cause weakness in the feet, ankles, legs, and sometimes hands, plus balance problems and foot deformities. Today there is no cure and no drug proven to stop or reverse CMT, and treatment is focused on symptoms, function, and quality of life. NMD Pharma+2Physiopedia+2

This condition is also called CMT1C. It is caused by a change (mutation) in a gene called LITAF, which stands for “lipopolysaccharide-induced TNF-alpha factor.” This gene is also known as SIMPLE. When LITAF is changed, it affects how nerve cells handle certain proteins, and this leads to damage of the myelin around the peripheral nerves.PubMed+1

CMT1C usually runs in families in an autosomal dominant pattern. This means that a person only needs one copy of the changed gene from one parent to get the disease. Family members across generations may have similar problems with weakness, numbness, and foot shape changes.Monarch Initiative+1

The main feature of this type is slow nerve conduction on nerve tests. In demyelinating forms of CMT, nerve conduction velocities are often less than about 38 meters per second, which is much slower than normal. This slow conduction helps doctors recognise that the problem is mainly in the myelin and not mainly in the nerve axon itself.MalaCards+1

Clinically, people with CMT1C often have slowly progressive symptoms. They may develop weakness in the feet and lower legs, difficulty lifting the front of the foot (foot drop), high-arched feet (pes cavus), and reduced or absent ankle reflexes. Sensory loss such as numbness or tingling in a “stocking and glove” pattern is also common.NCBI+1

Other names

Charcot-Marie-Tooth slow nerve conduction type C is known by several other names in the medical literature. One common name is “Charcot-Marie-Tooth disease type 1C” or simply “CMT1C.” This name shows that it is part of the type 1 group (demyelinating) and that it is the “C” subtype.National Organization for Rare Disorders+1

Another name often used is “CMT, slow nerve conduction type C.” This term highlights the key feature of very slow nerve conduction velocities and the “C” subtype within the slow-conduction forms. It is also described as “neuropathy, hereditary motor and sensory, LITAF-related,” which points to the affected gene.National Organization for Rare Disorders+1

Some papers refer to it as “CMT1C due to LITAF/SIMPLE mutation.” Here, authors focus on the genetic cause. They describe it as an autosomal dominant demyelinating peripheral neuropathy with clinical features similar to other CMT1 forms but often milder muscle weakness and characteristic conduction slowing.PubMed+1

Types

Within Charcot-Marie-Tooth slow nerve conduction type C, doctors and researchers may talk about “types” or sub-patterns based on how the disease looks and how tests appear, even though they all share LITAF mutations.

One way to look at types is by age at onset:

  • Childhood-onset CMT1C

  • Adolescent-onset CMT1C

  • Adult-onset CMT1C

Some families show symptoms starting in school age, while others may not notice weakness until teen years or adult life.SciSpace+1

Another way is by severity:

  • Mild CMT1C (minimal weakness, mainly sensory loss and foot shape changes)

  • Moderate CMT1C (clear weakness, foot drop, walking difficulty)

  • Severe CMT1C (marked distal weakness and disability, though this is less common for LITAF-related disease compared with some other CMT types)

Studies of families with common LITAF mutations such as G112S show that many people have mild to moderate disease, with less severe weakness than some other CMT1 forms.SciSpace+1

A third way is by the pattern of nerve conduction changes:

  • Uniform conduction slowing in most nerves

  • Conduction slowing with conduction block or patchy slowing in some nerves

CMT1C has been reported as a primary demyelinating neuropathy, but in some patients nerve studies show patchy slowing and conduction blocks, which can sometimes be confused with inflammatory neuropathies.Springer+1

Causes

It is important to understand that CMT1C has one main root cause: a genetic mutation in the LITAF gene. The “causes” listed below are ways of describing that genetic cause and related factors that influence how the disease appears or worsens over time, not separate independent diseases.

  1. LITAF gene mutation
    The primary cause of CMT slow nerve conduction type C is a harmful change in the LITAF (also called SIMPLE) gene. These mutations alter a protein involved in cellular protein handling and may disturb myelin maintenance in peripheral nerves, leading to demyelination and slow nerve conduction.PubMed+1

  2. Autosomal dominant inheritance pattern
    Because the condition is autosomal dominant, inheriting one mutated copy of LITAF from an affected parent is enough to cause disease. This inheritance pattern explains why the condition often appears in many members across several generations in a family.Monarch Initiative+1

  3. Protein mislocalization and aggregation in Schwann cells
    Experimental studies suggest that some LITAF mutations cause the protein to mis-localize within cells or form aggregates. In Schwann cells (the cells that make myelin), this can disturb endosomal and lysosomal pathways, harming myelin stability around axons.PubMed+1

  4. Demyelination of peripheral nerves
    Abnormal LITAF function leads mainly to demyelination rather than primary axon loss. Loss or damage of myelin slows the speed of electrical signals along the nerve, which is reflected in reduced nerve conduction velocities and the clinical signs of weakness and sensory loss.MalaCards+1

  5. Secondary axonal damage over time
    Although the primary problem is demyelination, long-lasting demyelination can eventually lead to axonal damage. Over years, this contributes to muscle wasting (atrophy) and more pronounced weakness in the feet and hands.NCBI+1

  6. Gene-specific differences in severity
    Different LITAF mutations (for example G112S, T115N, W116G, R160H) may cause different levels of functional damage. Some variants are linked to milder disease, while others may be associated with more conduction block or more symptoms.PubMed+1

  7. Family-specific genetic background
    Other genes in a person’s genetic background may modify how severe the LITAF mutation effect is. This can partly explain why some family members are more affected than others even when they carry the same LITAF mutation.ResearchGate+1

  8. Length-dependent vulnerability of long nerves
    Long nerves, such as those going to the feet, are more sensitive to demyelination and conduction slowing. This length-dependent effect explains why symptoms usually start in the feet and lower legs and later involve the hands.NCBI+1

  9. Mechanical stress on already weak muscles and nerves
    Abnormal foot shape and muscle imbalance can put extra stress on nerves and joints. Over time, this mechanical stress may worsen symptoms like pain, fatigue, and instability, though it is not the original cause.ScienceDirect+1

  10. Superimposed acquired neuropathy (for example diabetes)
    In some people with CMT, added conditions like diabetes or vitamin deficiencies can cause additional nerve damage. This is not the cause of CMT1C itself but can make symptoms more severe and can complicate diagnosis.NCBI+1

  11. Immune or inflammatory mechanisms (research area)
    Recent research suggests LITAF is involved in inflammatory pathways. Some studies explore whether altered LITAF may make nerves more sensitive to inflammatory stress, though this remains an area of ongoing research rather than a proven direct cause.MDPI+1

  12. Delayed diagnosis and lack of supportive care
    When the disease is not recognised early, people may not receive braces, physiotherapy, or orthopaedic support. This does not cause the genetic disease but allows secondary problems such as contractures and falls to become worse.ClinMed Journals+1

  13. Poor footwear and repeated ankle injuries
    High-arched, unstable feet are prone to sprains and falls. Poor shoes and repeated ankle injuries can worsen pain and disability, adding to the effects of the underlying neuropathy.ScienceDirect+1

  14. Weight gain and reduced fitness
    Weak muscles and balance problems can reduce physical activity. If weight increases, walking becomes more tiring and joint stress rises, which can worsen function and quality of life in someone who already has CMT1C.ClinMed Journals+1

  15. Co-existing spinal problems
    Some people develop scoliosis or other spinal deformities related to muscle imbalance. These spinal changes can further affect gait and posture, adding to disability.Orthobullets+1

  16. Misdiagnosis as inflammatory neuropathy
    Because some CMT1C patients show conduction block or patchy slowing, they may be misdiagnosed as having acquired inflammatory neuropathy and may receive treatments that are not helpful. This delay in correct diagnosis may affect long-term planning and genetic counselling.Springer+1

  17. Lack of genetic counselling in families
    Without genetic counselling, family members may not understand the risk of passing the condition on. This does not change the biology but influences how widely the mutation spreads in a family over generations.BCBSM+1

  18. Psychological stress and reduced coping
    Living with a chronic, inherited neuropathy can cause emotional stress, anxiety, or depression. This can worsen the perception of pain, fatigue, and disability, although it does not change the underlying nerve damage.ClinMed Journals+1

  19. Limited access to specialist neuromuscular care
    In some regions, people may not have access to neurologists, genetic testing, or multidisciplinary teams. This can lead to under-treatment of symptoms such as foot deformities, scoliosis, and pain.ClinMed Journals+1

  20. Age-related progression
    Even without new external triggers, CMT1C typically progresses slowly with age. More years of demyelination and axonal stress naturally lead to more weakness, deformity, and functional limits over time.NCBI+1

Symptoms

  1. Distal muscle weakness in the feet and lower legs
    The most common early symptom is weakness in the muscles that lift and move the feet and ankles. People often notice tripping, difficulty running, or trouble walking on uneven ground. This weakness reflects length-dependent motor nerve involvement.NCBI+1

  2. Foot drop
    Because the muscles that lift the front of the foot are weak, the toes may drag on the ground during walking. This is called foot drop. People may adopt a “steppage gait,” lifting the knees higher to avoid tripping.Orthobullets+1

  3. Pes cavus (high-arched feet)
    Many people develop high-arched feet due to imbalance between muscle groups. The intrinsic muscles of the feet become weak, while some stronger muscles pull the foot into an abnormal shape. Pes cavus is a classic sign of CMT and related neuropathies.NCBI+1

  4. Claw or hammer toes
    Toes may curl down or appear “clawed” because of weakness and imbalance in the small foot muscles and long toe flexors. These deformities can cause pressure points, calluses, and pain when standing or walking.Orthobullets+1

  5. Distal muscle wasting (atrophy)
    Over time, the muscles of the lower legs may shrink, giving a “stork leg” or “inverted champagne bottle” appearance, where the calves look thin above relatively normal-sized knees. This reflects chronic denervation and re-innervation in the distal muscles.Rom J Morphol Embryol+1

  6. Numbness and tingling in feet and hands
    Sensory symptoms such as numbness, tingling, or “pins and needles” often start in the toes and feet and may later affect the fingers. This is due to damage to sensory nerve fibers and is usually length-dependent.NCBI+1

  7. Reduced vibration and position sense
    Many patients lose the ability to sense vibration (for example from a tuning fork) and the exact position of their toes or ankles. This loss of proprioception contributes to unsteady walking and balance problems, especially in the dark.NCBI+1

  8. Absent or reduced deep tendon reflexes
    Reflexes at the ankles and sometimes at the knees are often reduced or absent because the reflex arc depends on healthy peripheral nerves. Loss of ankle jerks is a frequent examination finding in CMT.NCBI+1

  9. Difficulty with balance and frequent falls
    Weakness, sensory loss, and foot deformities together make balance difficult. People may sway when standing still or fall easily, especially in poorly lit areas, on uneven surfaces, or when tired.ClinMed Journals+1

  10. Hand weakness and difficulty with fine tasks
    As the disease progresses, weakness may also appear in the hands. People may struggle with buttons, zippers, handwriting, or opening jars. This reflects involvement of the long nerves to the hands.NCBI+1

  11. Muscle cramps and fatigue
    Some individuals report painful muscle cramps, especially in the calves or feet, and general fatigue with walking or standing. These symptoms may be related to overuse of remaining muscles and altered nerve activation.NCBI+1

  12. Neuropathic pain (burning or shooting pain)
    While pain is less prominent in some hereditary neuropathies than in acquired ones, some patients with CMT do experience burning, shooting, or aching pain in the feet and legs due to nerve damage.neurology-asia.org+1

  13. Scoliosis or spinal curvature
    Muscle imbalance in the trunk and paraspinal muscles can contribute to spinal curvature in some patients. Scoliosis may cause back pain, cosmetic concerns, and reduced lung capacity in more severe cases.Orthobullets+1

  14. Tremor or shakiness (in some CMT forms)
    Certain CMT types may have tremor, although this is more strongly linked to other subtypes like Roussy-Lévy syndrome. Some individuals with demyelinating CMT report hand tremor, which can worsen fine motor tasks.Rom J Morphol Embryol+1

  15. Impact on daily activities and quality of life
    Together, these symptoms make everyday tasks such as walking long distances, climbing stairs, or working with the hands more difficult. Many patients report reduced physical function and psychological impact, including worry about future disability and family members.ClinMed Journals+1

Diagnostic tests

Physical examination tests

  1. Full neurological history and physical exam
    The doctor first takes a detailed history, asking about weakness, numbness, falls, family history, and age at symptom onset. They then examine muscle strength, sensation, reflexes, and coordination. A length-dependent pattern of distal weakness and sensory loss with reduced reflexes and foot deformities suggests a hereditary motor and sensory neuropathy like CMT1C.PMC+1

  2. Gait observation and walking assessment
    The clinician watches how the person walks, looking for foot drop, steppage gait, ankle instability, or use of aids. They may ask the person to walk on heels, toes, and in a straight line. Difficulties with heel-walking and a high-stepping gait strongly point to distal leg weakness.Orthobullets+1

  3. Inspection of feet and legs for deformities
    The doctor examines the shape of the feet and legs, looking for pes cavus, claw toes, calluses, and muscle wasting in the calves and feet. These visible changes provide important clues that the neuropathy is long-standing and inherited.ScienceDirect+1

  4. Reflex testing with a reflex hammer
    Deep tendon reflexes at ankles and knees are tested. In CMT1C and other demyelinating CMT types, ankle reflexes are often absent, and knee reflexes may also be reduced. This helps distinguish peripheral neuropathy from problems in the brain or spinal cord.MalaCards+1

  5. Sensory examination (touch, pain, temperature)
    Light touch, pin-prick, temperature, and vibration are checked in the feet and hands. In CMT, reduced vibration and position sense are especially common, and sensory loss usually follows a “stocking and glove” pattern.NCBI+1

Manual bedside tests

  1. Manual muscle testing (MRC grading)
    The examiner tests muscle strength by asking the patient to move against resistance and grades strength using a simple scale (for example, 0–5). Distal muscles such as ankle dorsiflexors and toe extensors are often weaker than proximal muscles in CMT1C.NCBI+1

  2. Tuning fork vibration test
    A vibrating tuning fork (often 128 Hz) is placed on bony points such as the toes and ankles. People with CMT frequently feel vibration poorly or not at all at the toes, indicating large-fiber sensory involvement.NCBI+1

  3. Romberg test for balance
    The patient stands with feet together and eyes open, then closes their eyes. If they sway or fall when eyes are closed, this suggests impaired proprioception (position sense), which is common in CMT and contributes to balance problems.NCBI+1

  4. Heel-to-toe (tandem) walking test
    Walking in a straight line, placing the heel of one foot directly in front of the toes of the other, is a simple way to test balance and coordination. People with CMT1C may show instability because of sensory loss and distal weakness.ClinMed Journals+1

  5. Hand dexterity tests (for example, buttoning, writing)
    Simple bedside tasks like buttoning a shirt, writing, or picking up small objects can show subtle hand weakness and incoordination as the disease progresses proximally to the hands.NCBI+1

Laboratory and pathological tests

  1. Basic blood tests to rule out acquired neuropathies
    Blood tests for diabetes (glucose, HbA1c), vitamin B12, thyroid function, kidney and liver function, and autoimmune markers may be performed. Normal results do not diagnose CMT1C, but they help rule out acquired neuropathies that could mimic or worsen symptoms.hopkinsmedicine.org+1

  2. Genetic testing panel for hereditary neuropathies
    Once nerve conduction studies show a demyelinating neuropathy, a genetic panel including common CMT genes is recommended. LITAF is one of the genes tested when CMT1A (PMP22 duplication) is negative. Identifying a pathogenic LITAF variant confirms CMT1C.bluecrossnc.com+1

  3. Targeted LITAF gene sequencing
    In families where a specific LITAF mutation is already known, targeted sequencing can be used to test relatives. This allows early diagnosis, counselling, and screening even before severe symptoms appear.PubMed+1

  4. Nerve biopsy (rarely used now)
    In uncertain cases, a small piece of sensory nerve (often the sural nerve) may be taken for microscopic examination. Demyelinating CMT shows onion bulb formations from repeated demyelination and remyelination. However, with modern genetic testing, nerve biopsy is much less common.MalaCards+1

  5. Muscle biopsy (in selected cases)
    Occasionally, muscle biopsy may be done to evaluate chronic denervation changes or to help distinguish neuropathy from primary muscle disease. In CMT, findings usually show neurogenic atrophy rather than primary myopathy.PMC+1

Electrodiagnostic tests

  1. Motor nerve conduction studies (NCS)
    Motor NCS measure how fast and how strongly electrical signals travel along motor nerves. In CMT1C, conduction velocities are uniformly slowed and amplitudes may be reduced, indicating demyelinating neuropathy. Velocities often fall below about 38 m/s in affected nerves.MalaCards+1

  2. Sensory nerve conduction studies
    Sensory NCS check the speed and size of sensory responses. In CMT1C, sensory nerve conduction velocities are also reduced and may show mild to moderate slowing, consistent with demyelination and sensory loss.PMC+1

  3. Electromyography (EMG)
    EMG uses a fine needle electrode to record electrical activity in muscles. In demyelinating CMT, EMG may show signs of chronic denervation and re-innervation but often less active denervation than in primary axonal neuropathy. EMG helps to confirm peripheral nerve involvement and rule out primary muscle disorders.PMC+1

Imaging tests

  1. X-ray of feet and spine
    Plain X-rays can show bony deformities such as pes cavus, claw toes, and scoliosis. While they do not diagnose neuropathy directly, they help orthopaedic planning for braces or surgery and show the structural impact of long-standing muscle imbalance.ScienceDirect+1

  2. MRI to rule out other causes
    MRI of the spine or brain is not used to diagnose CMT1C itself but may be done to exclude other causes of weakness and sensory loss, such as spinal cord lesions or brain disease. In complex cases, imaging helps ensure that symptoms are truly due to hereditary neuropathy and not an overlapping central nervous system problem.Nepal Journals Online+1


Non-Pharmacological Treatments (Therapies and Others)

Physical therapy strengthening programs
A physical therapist designs safe exercises to strengthen the muscles that still respond to weak nerve signals. The aim is to keep legs, ankles, and core as strong as possible without over-working tired muscles. Exercises are usually low-impact, such as gentle resistance bands or light weights, done a few times per week. This helps walking, climbing stairs, and daily tasks. Stronger muscles also protect joints from deformity and reduce falls. Evidence in CMT and other neuropathies shows that regular, supervised exercise improves function and fatigue without worsening nerve damage. nhs.uk+1

Stretching and contracture prevention
Slow nerves and weak muscles can cause tight Achilles tendons, bent toes, and stiff ankles. Daily stretching of calves, hamstrings, and feet helps keep joints moving. A therapist teaches simple stretches that can be done at home, often holding each stretch for 20–30 seconds. The purpose is to prevent contractures (fixed stiffness) that limit walking and make shoes hard to wear. Stretching also reduces morning stiffness and muscle cramps. Keeping good range of motion can delay or reduce the need for surgery on feet and ankles. nhs.uk+1

Balance and gait training
Because CMT affects ankle and foot muscles, many people walk with a high-stepping “foot drop” gait and lose balance easily. A therapist can teach balance exercises such as standing on one leg with support, side stepping, and walking on different surfaces. They also train safe ways to turn, step over obstacles, and recover from stumbles. The purpose is to cut the risk of falls and injuries and to build confidence in moving. Gait training may include treadmill work or outdoor practice with supervision. nhs.uk+1

Occupational therapy for hand and daily skills
Occupational therapists focus on hand weakness and fine motor problems, such as difficulty buttoning clothes, writing, or using a phone. They teach joint-protecting techniques and grip-saving tricks, and may suggest built-up pens, special cutlery, or zipper pulls. The goal is to stay independent in school tasks, self-care, and hobbies. Occupational therapy also teaches energy saving methods, such as planning breaks and using wheeled bags instead of heavy backpacks, to reduce fatigue. Physiopedia+1

Ankle–foot orthoses (AFOs)
AFOs are light plastic or carbon-fiber braces worn inside or with shoes to support weak ankles and prevent foot drop. They hold the ankle at a safe angle, making it easier to clear the toes when walking and reducing trips. Some braces are flexible for sports; others are stiffer for heavier support. The orthotist customizes them to fit the leg and foot. AFOs have strong evidence in CMT for improving walking speed, endurance, and safety, especially in people with slow nerve conduction and foot drop. nhs.uk+2Physiopedia+2

Custom footwear and insoles
CMT often causes high arches or flat feet, clawed toes, and pressure points. Special shoes with good depth, wide toe boxes, and strong heels help protect the feet. Custom insoles or orthotic inserts spread pressure evenly and support the arch. This reduces pain, blisters, and calluses, and lowers the risk of skin breakdown and ulcers. Proper footwear also helps balance by creating a stable base under the AFOs or braces. nhs.uk+1

Assistive walking devices (cane, crutches, walker)
If balance and strength are very limited, a cane, forearm crutch, or walker may be recommended. The purpose is to give extra points of support, reducing fear of falling and allowing longer distances with less fatigue. A therapist fits and trains the person in safe use, including how to climb stairs or curbs. Using a device is not a “failure”; it is a tool to stay active and independent while nerves are weak. nhs.uk+1

Aquatic therapy (water-based exercise)
Swimming or exercises in a warm pool are gentle on joints and weak muscles. Water supports body weight, so movements like walking, leg lifts, or gentle jumping can be practiced with less pain and risk. The purpose is to build endurance and strength safely, especially for people with slow nerve conduction and fatigue. Warm water also relaxes stiff muscles and can improve mood. Aquatic therapy is commonly recommended for chronic neuropathies and is considered safe when supervised. Charcot-Marie-Tooth Association+1

Low-impact aerobic exercise
Regular low-impact exercise such as cycling, swimming, or walking on flat ground improves heart fitness, energy, and mood. In CMT, the goal is not to build big muscles but to stay active without over-tiring weak nerves. Short, frequent sessions with rest breaks are usually better than one long, hard workout. A therapist or doctor can help set safe targets. Studies in inherited neuropathies suggest that moderate exercise improves function without worsening nerve damage. PMC

Postural and ergonomic training
Weak core and leg muscles can lead to poor posture, back pain, and neck strain. Therapists teach sitting and standing positions that protect the spine, plus simple core exercises. They also review school or computer setups: chair height, desk height, and screen position. Ergonomic changes reduce strain and headaches and make studying or computer work less tiring. This is especially important for teens who spend many hours sitting. Charcot-Marie-Tooth Association+1

Splints for hands and feet
Soft or hard splints can support weak wrists or fingers, making it easier to write, type, or grip objects. Night splints for ankles or toes can keep them in a neutral position and reduce morning stiffness. The purpose is to protect joints, prevent deformity, and improve function. Splints are usually custom-made by an occupational therapist or orthotist and adjusted as the person grows or as symptoms change. Physiopedia+1

Fall-prevention and home safety modification
People with CMT have a higher fall risk because of foot drop and poor sensation. Therapists can review the home and suggest safety changes: removing loose rugs, adding grab bars, improving lighting, or using non-slip mats. They also teach strategies like turning slowly, using rails, and choosing safe shoes. These changes greatly reduce injuries such as ankle sprains and fractures. nhs.uk+1

Energy conservation and fatigue management
Slow nerve conduction means movements cost more energy. Occupational therapists teach pacing: breaking tasks into smaller steps, planning rest breaks, and spreading heavy tasks across the day. They may suggest tools like rolling backpacks or stools in the kitchen. The goal is to reduce exhaustion while still allowing school, hobbies, and social life. Learning these skills early can prevent burnout and improve mood. Charcot-Marie-Tooth Association+1

Respiratory therapy (when needed)
In a small number of cases, CMT can affect the diaphragm or chest muscles. If breathing or cough becomes weak, respiratory therapists teach breathing exercises, cough-assist techniques, or nighttime non-invasive ventilation. The purpose is to keep the lungs clear, prevent infections, and improve sleep quality. Regular monitoring of lung function can catch problems early. PMC

Speech and swallowing therapy (if bulbar nerves are involved)
If speech becomes nasal or swallowing is difficult, a speech-language therapist can help. They assess which muscles are weak and teach exercises and safe swallowing methods. They may suggest changes in food texture or pace of eating. The goal is to prevent choking, weight loss, and social embarrassment. Support in school can also be arranged if speech is affected. PMC

Psychological counseling and cognitive-behavioural therapy (CBT)
Living with a chronic genetic disease can cause sadness, anxiety, or low self-esteem. CBT and supportive counseling help people cope with pain, fatigue, and worries about the future. Therapists teach skills to manage stress and negative thoughts and to communicate better with family and friends. Treating mental health is a vital part of CMT care and can improve pain perception and daily functioning. PMC

Genetic counseling for patient and family
Genetic counselors explain the type of CMT, the inheritance pattern, and chances of passing it to children. They help family members decide whether they want genetic testing and discuss options such as prenatal testing or future gene-targeted therapies. This information can reduce guilt and confusion and support life planning. It is also important for relatives who may have mild symptoms but no diagnosis. PMC

Patient education and self-management training
Understanding how CMT affects nerves and muscles helps people make better choices. Education covers exercise safety, foot care, early signs of complications, and when to contact a doctor. Simple written plans or apps can remind people of stretches and medication times. Good self-management is linked to better outcomes in many chronic diseases, and CMT is no exception. Charcot-Marie-Tooth Association+1

Peer support groups and community resources
Support from others with CMT reduces feelings of isolation. Patient groups and online communities share practical tips about shoes, braces, school issues, and new research. They also organize workshops and physiotherapy guides. Feeling understood improves mental health and encourages people to follow treatment plans. Many CMT organizations also connect patients to research studies and clinical trials. Charcot-Marie-Tooth Disease+1

Vocational and school accommodations
As teens grow up, they may worry about careers and work. Vocational counselors and school support teams can help choose jobs and study paths that match abilities and limitations. They arrange reasonable accommodations, such as extra exam time, accessible desks, or flexible work tasks. This helps people stay engaged in education and work, which strongly supports long-term psychological and financial health. Charcot-Marie-Tooth Association+1


Drug Treatments

Right now, no drug is proven and approved to cure or slow CMT itself, including slow nerve conduction type C. Medicines are used mainly to control neuropathic pain, cramps, mood, and sleep problems. Most evidence comes from studies in other neuropathies, such as diabetic neuropathy or post-herpetic neuralgia, not directly from CMT. All drugs below must be prescribed and monitored by a doctor; doses here are typical examples from FDA labels or guidelines and may not fit you. NMD Pharma+2Physiopedia+2

To stay within space and avoid unsafe detail, I will describe a core group of commonly used, evidence-based medicines:

Gabapentin (Neurontin)
Gabapentin is an anti-seizure medicine widely used for neuropathic pain. In CMT, it does not fix slow nerve conduction but can reduce burning, tingling, and shooting leg pain. Typical adult dosing for neuropathic pain starts at 300 mg once daily and increases over days to 900–1800 mg/day in divided doses, adjusted by the doctor and kidney function. Mechanism: it binds to calcium channels in nerve cells and reduces release of excitatory neurotransmitters, calming over-active pain pathways. Common side effects include sleepiness, dizziness, swelling of legs, and weight gain; it can also affect mood in some people. FDA Access Data+1

Pregabalin (Lyrica)
Pregabalin is similar to gabapentin but often works at lower doses and with more predictable absorption. It is approved for several neuropathic pain conditions. In CMT, it is used off-label to manage chronic burning or electric-shock-like pain in feet and legs. Typical adult doses for neuropathic pain start at 150 mg/day in two or three doses and may be increased up to 300–600 mg/day if needed and tolerated. Mechanism: binds to α2-δ subunits of calcium channels, reducing neurotransmitter release and pain signaling. Side effects can include dizziness, drowsiness, swelling, weight gain, and blurry vision. FDA Access Data+1

Duloxetine (Cymbalta)
Duloxetine is a serotonin-noradrenaline reuptake inhibitor (SNRI) antidepressant approved for diabetic peripheral neuropathic pain and fibromyalgia. In CMT, it may be used when pain and low mood occur together. Usual adult neuropathic pain dose is 60 mg once daily, sometimes starting at 30 mg. Mechanism: by blocking reuptake of serotonin and noradrenaline, it strengthens descending pain-control pathways in the spinal cord. Side effects include nausea, dry mouth, sweating, sleep changes, increased blood pressure, and in diabetic patients sometimes worse blood sugar control, so monitoring is essential. FDA Access Data+1

Amitriptyline (low-dose tricyclic antidepressant)
Amitriptyline is an older antidepressant widely used in low doses for neuropathic pain and sleep problems. In CMT, a small bedtime dose (for example 10–25 mg, adjusted by the doctor) can help dull nighttime pain and improve sleep. Mechanism: similar to SNRIs, it enhances serotonin and noradrenaline and also blocks certain pain-related receptors. Side effects are dry mouth, constipation, weight gain, blurry vision, and sometimes heart rhythm changes; it is used with special caution in young people and those with heart disease.

Nortriptyline
Nortriptyline is a related tricyclic with slightly fewer sedating and anticholinergic effects than amitriptyline. It may be chosen if amitriptyline is not tolerated. Typical low starting doses are 10–25 mg at night, slowly increased if needed. Mechanism is similar: boosting descending pain-control pathways and modulating sodium channels. Side effects include dry mouth, constipation, dizziness, and possible heart rhythm effects, so ECG monitoring may be needed in some patients.

Topical lidocaine 5% patch
A lidocaine patch is placed on painful skin areas (often the feet) for up to 12 hours a day. Lidocaine blocks sodium channels in peripheral nerves, reducing abnormal pain firing without many systemic side effects. It is useful for localized neuropathic pain and can be combined with oral medicines. Common issues are mild skin redness or irritation. It avoids sedation and is sometimes preferred in people who cannot tolerate oral drugs.

Topical capsaicin patch or cream
Capsaicin, from chili peppers, depletes substance P and desensitizes pain fibers when applied repeatedly. High-strength patches are applied in clinics; low-strength creams are used at home. In CMT, it may reduce burning pain in the feet. Early burning or stinging sensation is common but usually settles with regular use. It should be kept away from eyes and broken skin.

Tramadol (weak opioid with SNRI activity)
Tramadol is a centrally acting pain medicine used for moderate pain that does not respond to first-line drugs. It acts partly like an opioid and partly like an SNRI. Doctors use the lowest effective dose for the shortest time because of risks of dependence, drowsiness, nausea, and, rarely, seizures or serotonin syndrome when combined with other antidepressants. It is not a first choice in children or teens.

Baclofen (muscle relaxant)
Baclofen is a GABA-B receptor agonist used to treat spasticity and sometimes painful muscle spasms. In CMT, if there is spasticity or severe cramps, baclofen may help relax the muscles. Doses start low and are increased slowly. Side effects include weakness, drowsiness, and dizziness. Abrupt stopping can be dangerous, so any change must be guided by a doctor.

Tizanidine
Tizanidine is another muscle relaxant that acts on alpha-2 adrenergic receptors in the spinal cord to reduce muscle tone. It may be used for painful spasms interfering with sleep or mobility. It can cause low blood pressure, dry mouth, and sleepiness, so it is started at small doses at night. Liver function tests are sometimes monitored.

(In real clinical practice, doctors usually choose a few of these medicines, not twenty different drugs at once. Other drugs, such as SSRIs for depression or sleeping tablets, may be used based on individual needs. Always follow local guidelines and your neurologist’s advice.)


Dietary Molecular Supplements

Supplements cannot cure CMT, but some may support general nerve health when used carefully. Evidence is limited, and doses must be checked with your doctor to avoid harm or interactions.

Vitamin B12 (cobalamin)
Vitamin B12 is vital for myelin formation and normal nerve function. Low B12 can itself cause neuropathy, so correcting deficiency is important in any person with nerve disease. Typical oral doses in deficiency range from 500–1000 micrograms daily, or injections are used if absorption is poor. Mechanism: supports DNA synthesis in nerve cells and maintains myelin. Too much B12 is usually safe but should still be supervised, especially with other illnesses.

Vitamin B1 (thiamine) / benfotiamine
Thiamine is needed for nerve energy metabolism. Benfotiamine is a fat-soluble form often used in diabetic neuropathy studies. Oral doses vary (for example 150–300 mg/day in some trials). Mechanism: improves glucose handling in nerves and may reduce harmful metabolic by-products. It is generally well tolerated, but long-term use should be checked by a doctor.

Vitamin B6 (pyridoxine – careful with dose)
Vitamin B6 at low doses is important for neurotransmitter synthesis, but high doses for long periods can actually damage nerves. Doctors may give small doses (for example 10–25 mg/day) if diet is poor, but they avoid large doses above about 100 mg/day in adults. Mechanism: cofactor in many nerve enzyme reactions. Because overdose can cause neuropathy, this supplement should never be taken in high doses without medical supervision.

Alpha-lipoic acid (ALA)
ALA is an antioxidant studied in diabetic neuropathy. Typical study doses are around 600 mg/day, sometimes higher in short courses. Mechanism: reduces oxidative stress and may improve blood flow in small vessels around nerves. Side effects can include nausea and skin rash, and it may affect blood sugar, so diabetic patients need close monitoring. Evidence in CMT is limited but it may be considered as a supportive option.

Omega-3 fatty acids (fish oil)
Omega-3 fats from fish oil support membrane structure and have anti-inflammatory effects. Common supplement doses are 1–2 grams of combined EPA+DHA per day, but this must be individualized. They may support cardiovascular health and general nerve well-being. Mechanism: incorporate into cell membranes and produce anti-inflammatory mediators. Side effects can include stomach upset and, at higher doses, a slight increase in bleeding risk.

Vitamin D
Vitamin D supports bone and muscle function. Many people with chronic disease have low levels, and deficiency can worsen muscle weakness and falls. Doses depend on blood levels; doctors may use 800–2000 IU/day or short high-dose courses. Mechanism: regulates calcium and phosphate balance and supports muscle contraction. Too much can cause high calcium and kidney problems, so blood tests are needed.

Vitamin C (ascorbic acid)
Vitamin C is an antioxidant and has been studied in CMT1A, but large clinical trials did not show clear benefit on disease progression. PMC Still, normal dietary intake (for example 75–100 mg/day) is important for general health and collagen formation. High-dose supplements are not recommended as a treatment for CMT type C without specialist advice because benefits are uncertain.

Coenzyme Q10
CoQ10 is involved in mitochondrial energy production. It has been tried in various neuromuscular disorders. Common supplement doses range from 100–300 mg/day, divided doses. Mechanism: improves electron transport in mitochondria and acts as an antioxidant. Side effects can include stomach upset and insomnia. Evidence in CMT is weak, so it should be viewed as experimental support, not a proven therapy.

Acetyl-L-carnitine
Acetyl-L-carnitine helps transport fatty acids into mitochondria and may support nerve regeneration in some animal and small human studies. Doses in studies often range from 500–2000 mg/day in divided doses. Possible benefits include reduced pain and improved nerve conduction in some neuropathies, but data are limited. It can cause nausea and restlessness in some people.

Magnesium
Magnesium plays a role in muscle relaxation and nerve conduction. Mild deficiency can worsen cramps and twitching. Supplemental doses usually range from 200–400 mg/day, but too much can cause diarrhea and, in kidney disease, dangerous levels. Mechanism: modulates NMDA receptors and nerve excitability. It may help with cramps in some people with neuropathies, but evidence is modest.


Regenerative, Immunity-Booster and Stem-Cell–Related Drugs

For CMT slow nerve conduction type C, there are no approved “stem cell drugs” or regenerative medicines that can be safely prescribed with fixed doses and long-term evidence. Research areas include:

  1. Gene therapy and gene-silencing (antisense oligonucleotides) – aiming to correct or silence the faulty gene.

  2. Small molecules targeting myelination – such as experimental compounds like PXT3003 or muscle-targeted drugs like NMD670, currently in trials. NMD Pharma+1

  3. Neurotrophic growth factors – lab studies use factors like NGF, BDNF, or neuregulins to support nerve survival.

  4. Schwann-cell or stem-cell transplantation – experimental attempts to replace or support myelin-forming cells.

  5. Immune-modulating drugs – mainly used in acquired neuropathies; they are not standard for classic inherited CMT.

  6. Combination approaches – where exercise, orthotics, and future gene-targeted drugs would be used together.

Because these therapies are still being tested, it would be unsafe and inaccurate to give fixed “dosages” or routine schedules. If you hear about a “stem cell cure” online, talk with your neurologist; many such offers are unproven or commercial and can be risky. PMC


Surgeries – Main Procedures and Why They Are Done

Foot deformity correction (osteotomy)
In CMT, muscle imbalance can create high arches (pes cavus) and clawed toes. Orthopaedic surgeons may cut and realign foot bones (osteotomy) to create a flatter, more stable foot. This surgery aims to improve weight-bearing, reduce pain, and help braces and shoes fit better.

Tendon transfer surgery
Surgeons can move functioning tendons to replace the action of weak muscles. For example, they may transfer a stronger tendon to lift the foot and reduce foot drop. The purpose is to balance the forces around the ankle and improve the walking pattern, often reducing the need for heavy braces.

Joint fusion (arthrodesis)
If joints, such as the ankle, are badly deformed or unstable, surgeons may fuse bones together so the joint no longer moves. This can relieve pain and create a stable base for walking, but sacrifices flexibility. It is usually considered after other options fail.

Toe surgery
Clawed toes can rub inside shoes and cause painful corns and ulcers. Surgeons can straighten toes by releasing tight tendons, removing small bone segments, or fusing small joints. The goal is to relieve pain, improve shoe fit, and reduce skin damage.

Spinal surgery for scoliosis (when present)
Some people with CMT develop curvature of the spine (scoliosis). If the curve is severe or progressing, spinal fusion with rods and screws may be recommended. The purpose is to prevent further curvature, protect lung function, and reduce back pain. This is usually done in specialist centers and only after careful discussion. Physiopedia+1


Prevention – Ways to Reduce Complications (Not Genes)

  1. Avoid known nerve-toxic drugs (for example some chemotherapy or high-dose B6) – your doctor can check any new medicine against your CMT.

  2. Protect your feet with daily inspection, proper footwear, and quick treatment of blisters or cuts.

  3. Use braces and orthotics as advised to prevent falls, sprains, and joint deformities.

  4. Exercise regularly but gently, choosing low-impact activities instead of high-impact sports that risk ankle injuries.

  5. Maintain a healthy body weight so weak muscles and joints are not overloaded.

  6. Do regular stretching to prevent fixed contractures and maintain joint motion.

  7. Stop smoking and avoid heavy alcohol use, because both can damage nerves further.

  8. Control other health problems such as diabetes or vitamin deficiencies that can worsen neuropathy.

  9. Attend regular follow-up with your neurologist and therapists to catch new problems early.

  10. Keep vaccinations up-to-date, especially against respiratory infections if breathing muscles are at risk. nhs.uk+2Physiopedia+2


When to See a Doctor

You should see a neurologist or specialist regularly for planned check-ups, and urgently if you notice sudden changes. Warning signs include: much worse weakness or balance over days or weeks; new severe pain, numbness, or burning; new breathing trouble, morning headaches, or poor sleep; trouble swallowing or speaking; frequent falls or new deformities; or mood changes such as strong sadness or anxiety that affect daily life. Any new drug, supplement, or “stem cell” offer should be checked with your doctor before starting. Parents or caregivers should also contact the care team if school performance drops because of fatigue or pain, so support can be arranged. Physiopedia+1


What to Eat and What to Avoid – Practical Points

  1. Eat a balanced diet with plenty of vegetables, fruits, whole grains, lean protein, and healthy fats to support overall strength and immunity.

  2. Include natural sources of B vitamins such as whole grains, eggs, fish, dairy, and legumes to support nerve health.

  3. Choose omega-3-rich foods like fatty fish (if allowed), flaxseed, and walnuts to support anti-inflammatory balance.

  4. Maintain good hydration, as dehydration can worsen cramps and fatigue.

  5. Limit sugary drinks and refined sweets, which can raise blood sugar and may worsen neuropathy risk if diabetes develops.

  6. Avoid heavy alcohol consumption, which directly damages nerves and can worsen weakness and sensation loss.

  7. Limit trans fats and very greasy fast foods, which add weight and harm heart and vessel health.

  8. Avoid crash diets or very low-calorie programs, because muscle and nerve health need enough calories and protein.

  9. Check with your doctor before taking any supplement, especially high-dose vitamins or herbal mixtures promoted online for “nerve repair.”

  10. If swallowing is hard, ask for a dietitian and speech therapist review to adjust food textures safely. PMC


Frequently Asked Questions (FAQs)

1. Can Charcot-Marie-Tooth slow nerve conduction type C be cured?
At present there is no cure and no approved medicine that stops or reverses CMT. Treatment focuses on symptoms, function, and quality of life. Research into gene-targeted drugs and other therapies is ongoing. NMD Pharma+1

2. Will exercise make my nerves worse?
Gentle, well-planned exercise usually does not damage nerves and can improve strength, balance, and mood. Over-exertion that causes long-lasting pain or extreme fatigue should be avoided. A physiotherapist can design a safe plan for you. Charcot-Marie-Tooth Association+1

3. Why are braces and orthotics so important?
Braces like AFOs support weak ankles and prevent foot drop, making walking safer and reducing falls. They also help keep joints in better alignment and may delay deformities.

4. Are pain medicines like gabapentin and pregabalin safe long term?
They can be safe when monitored, but they have side effects such as sleepiness, weight gain, and swelling. Doctors use the lowest effective dose and review regularly whether the medicine is still helping. Never change the dose on your own. FDA Access Data+2FDA Access Data+2

5. Do antidepressants mean my pain is “all in my head”?
No. Medicines like duloxetine or amitriptyline work on real nerve pathways in the brain and spinal cord that control pain. They are used in many physical pain conditions, not only in depression. FDA Access Data+1

6. Is surgery always needed for foot problems?
No. Many people manage well with shoes, insoles, and braces. Surgery is considered when deformities are painful, progressive, or stop braces and shoes from working. Decisions are made together with an experienced orthopaedic surgeon. Physiopedia+1

7. Can diet alone fix my neuropathy?
Diet cannot fix the genetic change or fully repair nerves, but good nutrition supports muscles, bones, and general health. It also helps maintain a healthy weight and energy level, which makes movement and rehabilitation easier.

8. Should I take lots of vitamin supplements?
High doses of some vitamins, like B6, can actually harm nerves. It is safer to aim for a balanced diet and only take supplements that your doctor or dietitian approves after checking blood levels.

9. Will CMT type C get worse forever?
CMT is usually slowly progressive, but the speed of change varies widely. Some people remain quite stable for many years, especially with good therapy and self-care. Regular monitoring helps track changes and adjust support. PMC

10. Can I play sports?
Many people with CMT enjoy sports like swimming, cycling, or adapted games. Contact sports or high-impact activities that risk ankle injuries may not be safe. Your therapist and doctor can guide you toward activities that fit your strength and balance.

11. Is it safe to have children if I have CMT?
CMT is genetic, so there is a chance of passing it on, but the exact risk depends on the specific gene. A genetic counselor can explain your type and the options available for family planning. PMC

12. What about experimental stem cell or gene therapies I see online?
Many of these are still in early research or are unregulated commercial offers. Some may be dangerous or very expensive without proven benefit. Always discuss any such option with your neurologist and check whether it is part of a registered clinical trial. Charcot-Marie-Tooth Disease+1

13. Does CMT affect life expectancy?
For many people with CMT, life expectancy is close to normal, especially if breathing and heart function are not severely affected. Quality of life can be greatly improved with braces, therapy, and good medical care. PMC

14. Can CMT cause breathing problems?
Sometimes, especially in more severe forms, the diaphragm or chest muscles may be affected, leading to night-time breathing problems. If you notice breathlessness, morning headaches, or poor sleep, you should see your doctor promptly. PMC

15. How often should I see my neurologist?
Most people with stable CMT are reviewed every 6–12 months, but visits may be more frequent if symptoms change quickly, new treatments start, or surgery is planned. Your neurologist will decide the right schedule with you. Physiopedia+1

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 25, 2025.

 

RxHarun
Logo